Stock Screener App

無料 - Play StoreApp Store

インストールインストール

Dow:

Nasdaq:

S&P 500:

DYAI

$0.38025.32%0.0192

アフターアワーズ： 0.39+0.01 +2.58%

Dyadic International Inc De (DYAI)

Date: O: H: L: C: Vol:

Dyadic International Inc De (DYAI) 最新ニュース

Dyadic International, Inc. Estimates – NASDAQ:DYAI - TradingView

Dyadic outlines commercial shift: what it means for Dyadic International stock - AD HOC NEWS

A passive stake tops 5% at Dyadic International (DYAI), with voting power shared. - Stock Titan

Nasdaq sets two tests for Dyadic International stock - ad-hoc-news.de

Dyadic International Inc Share Price - DYAI, RNS News, Articles, Quotes, & Charts (NASDAQ:DYAI) - Proactive financial news

Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS

Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS

Dyadic International (Nasdaq:DYAI) - Stock Analysis - Simply Wall Street

Dyadic International (DYAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dyadic International Faces Nasdaq Listing Compliance Challenges - The Globe and Mail

Form 8K Dyadic International Inc For: 25 September By Investing.com - Investing.com Nigeria

Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Dyadic gets Nasdaq notices over $1, $35M rules - Stock Titan

Dyadic International stock rises 2.5 percent as warrants add risk - AD HOC NEWS

Dyadic International stock trades without a fresh market catalyst - AD HOC NEWS

Dyadic International stock edges higher as S-1 registration becomes effective - AD HOC NEWS

DYADIC INTERNATIONAL INC SEC Filing (Sep 21, 2026) - Stock Titan

Dyadic International stock edges higher as S-1 registration becomes effective - ad-hoc-news.de

Emerging Growth Patterns Driving Rapid Expansion in the Protein Hydrolysis Enzymes Market - openPR.com

iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 - Finviz

Dyadic International (Nasdaq: DYAI) Advances Protein Manufacturing Platforms with Global Health Research Support - usatoday.com

Imperium AI Announces Board Discussion Regarding Dyadic Biotechnology Developments - usatoday.com

Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products - StreetInsider

Dyadic International (DYAI) Q2 2026 Earnings Call Transcript - AOL.ca

Amylase Enzyme Cleaner Market Growth to 2035 Driven by Membrane Filtration Demand - News and Statistics - IndexBox

Weekly Recap: H1 revenue rise, wider net loss and $2.9M share/warrant sale - TradingView

Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez - TradingKey

Dyadic International Announces New Equity Financing Agreements - TipRanks

Dyadic International (DYAI) Ergebniskonferenz Q2 2026: Kommerzielle Fortschritte und Liquiditätsrisiko - TradingKey

Dyadic International (NASDAQ: DYAI) prices $2.9M stock sale and warrant placement - Stock Titan

Dyadic International Earnings Call: Promise Amid Cash Strain - TipRanks

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Dyadic International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Dyadic raises $2.9 million in registered direct offering - Investing.com

Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder Value - TipRanks

Dyadic International Q2 Results: EPS Misses Estimate, Sales Down 0.6% YoY - scanx.trade

Dyadic Announces Second Quarter 2026 Financial Results - GlobeNewswire

Dyadic reports Q2 loss amid commercialization efforts - Investing.com

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas - Yahoo Finance

Dyadic International Inc (DYAI) (Q2 2026) Earnings Call Highlights: Revenue Surges 52% as ... - Yahoo Finance

Dyadic Q2 revenue slips 0.6% as net loss widens to $2.1 million - Quiver Quantitative

Earnings call transcript: Dyadic International Q2 2026 revenue beats, shares fall 16% - Investing.com

Earnings To Watch: Dyadic International Inc (DYAI) Q2 2026 -- GF Value Sees 40% Downside - Yahoo Finance

Cellulase Silage Additives Market Growth to 2035 Driven by Asia-Pacific Livestock Expansion - News and Statistics - IndexBox

Segmentation, Major Trends, and Competitive Overview of the Specialty Enzymes Market - openPR.com

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire

Dyadic signs license deal for precision-fermented dairy proteins - Investing.com

Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 - GlobeNewswire

DYAIに類似

NVCT$18.480.48%

ZVRA$10.280.77%